Yayınlar & Eserler

Yayın Ağı
Makaleler 120
Tümü (120)
SCI-E, SSCI, AHCI (117)
SCI-E, SSCI, AHCI, ESCI (120)
ESCI (3)
Scopus (119)
TRDizin (9)

1. The nature and correlates of childhood trauma in individuals at clinical-high risk (CHR) for psychosis: A cross-country study in Brazil, China and Turkey

Lopes-Rocha A. C., Hou C., Fekih-Romdhane F., Guliyev E. I., Uçok A., Loch A. A.
Asian Journal of Psychiatry , cilt.114, 2025 (SCI-Expanded, Scopus) identifier identifier

2. Longitudinal Study of P3a Potential in First-Episode Schizophrenia.

Devrim-Üçok M., Kıvanç-İnanöz B., Keskin-Ergen Y., Üçok A.
Clinical EEG and neuroscience , 2025 (SCI-Expanded) identifier identifier identifier

3. Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: Results from EU-GEI study

Andreu-Bernabeu Á., González-Peñas J., Mora A., Bernardo M., Mezquida G., Amoretti S., et al.
British Journal of Psychiatry , 2025 (SCI-Expanded) identifier identifier identifier

4. The relationship between childhood trauma, psychotic symptoms, and cognitive schemas in patients with schizophrenia, their siblings, and healthy controls: Results from the EU-GEI study

Üçok A., Noyan H., Gülöksüz S., SAKA M. C., ALPTEKİN K., Atbaşoǧlu C., et al.
Psychological Medicine , cilt.54, sa.10, ss.2414-2425, 2024 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

5. Discriminant analysis using MRI asymmetry indices and cognitive scores of women with temporal lobe epilepsy or schizophrenia

Fırat Z., Er F., Noyan H., Ekinci G., Üçok A., Uluğ A. M., et al.
Neuroradiology , cilt.66, sa.7, ss.1083-1092, 2024 (SCI-Expanded) identifier identifier

6. Face and emotion recognition in individuals diagnosed with schizophrenia, ultra-high risk for psychosis, unaffected siblings, and healthy controls in a sample from Turkey

Sağdıç M., Izgi B., Yapici Eser H., Ercis M., Üçok A., Kuşçu K.
Schizophrenia Research: Cognition , cilt.36, 2024 (ESCI) identifier identifier

7. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation.

van der Meer D., Cheng W., Rokicki J., Fernandez-Cabello S., Shadrin A., Smeland O. B., et al.
Schizophrenia bulletin , 2023 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier

8. Minor physical anomalies may be related to treatment resistance in patients with schizophrenia.

Uğurpala C., Berberoğlu E., Özkan U., Genç S. A., Tanrıverdi N. Ç., İnhanlı D., et al.
Asian journal of psychiatry , cilt.88, ss.103729, 2023 (SCI-Expanded) identifier identifier identifier

9. Measuring discrimination experienced by people with a mental illness: replication of the short-form DISCUS in six world regions

Brohan E., Thornicroft G., Rusch N., Lasalvia A., Campbell M. M., YALÇINKAYA ALKAR Ö., et al.
PSYCHOLOGICAL MEDICINE , cilt.53, sa.9, ss.3963-3973, 2023 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

10. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.

Fusar-Poli L., Prachason T., Erzin G., Pries L., Brondino N., Politi P., et al.
Psychiatry research , cilt.323, ss.115184, 2023 (SCI-Expanded) identifier identifier identifier

11. Visual P3 abnormalities in patients with first-episode schizophrenia, unaffected siblings of schizophrenia patients and individuals at ultra-high risk for psychosis.

Devrim-Üçok M., Keskin-Ergen H. Y., Üçok A.
Progress in neuro-psychopharmacology & biological psychiatry , cilt.122, ss.110678, 2023 (SCI-Expanded) identifier identifier identifier

12. Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium.

Smart S. E., Agbedjro D., Pardiñas A. F., Ajnakina O., Alameda L., Andreassen O. A., et al.
Schizophrenia research , cilt.250, ss.1-9, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

13. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

Fusar-Poli L., Pries L., van Os J., Radhakrishnan R., Pence A. Y., Erzin G., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.63, ss.1-14, 2022 (SCI-Expanded) identifier identifier identifier

14. Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS).

Polat I., Ince Guliyev E., Elmas S., Karakaş S., Aydemir Ö., Üçok A.
International journal of psychiatry in clinical practice , cilt.26, sa.3, ss.221-227, 2022 (SCI-Expanded) identifier identifier identifier

15. Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms

Ince Guliyev E., Guloksuz S., Ucok A.
JOURNAL OF CLINICAL MEDICINE , cilt.11, sa.17, 2022 (SCI-Expanded) identifier identifier identifier

16. Menstrual Cycle-Related Changes in Women with Schizophrenia: A Resting-State fMRI Study

Noyan H., HAMAMCI A., Firat Z., Sarsilmaz A., Ucok A.
NEUROPSYCHOBIOLOGY , cilt.81, sa.4, ss.296-310, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

17. Mapping genomic loci implicates genes and synaptic biology in schizophrenia.

Trubetskoy V., Pardiñas A. F., Qi T., Panagiotaropoulou G., Awasthi S., Bigdeli T. B., et al.
Nature , cilt.604, sa.7906, ss.502-508, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

18. Altered Resting State Functional Connectivity and Its Correlation with Cognitive Functions at Ultra High Risk for Psychosis

Bulbul O., Kurt E., Ulasoglu-Yildiz Ç., Demiralp T., Ucok A.
PSYCHIATRY RESEARCH-NEUROIMAGING , cilt.321, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

19. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

Fusar-Poli L., Pries L., van Os J., Erzin G., Delespaul P., Kenis G., et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.113, 2022 (SCI-Expanded) identifier identifier identifier

20. European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study

Dollfus S., Mucci A., Giordano G. M., Bitter I., Austin S. F., Delouche C., et al.
FRONTIERS IN PSYCHIATRY , cilt.13, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

21. Relationship of negative symptom severity with cognitive symptoms and functioning in subjects at ultra-high risk for psychosis

Ucok A., Direk N., Kaya H., Caglar N., Cikrikcili U., Noyan H., et al.
EARLY INTERVENTION IN PSYCHIATRY , cilt.15, sa.4, ss.966-974, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

22. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings

Noyan H., ERDAĞ E., TÜZÜN E., YAYLIM İ., KÜÇÜKHÜSEYİN Ö., HAKAN M. T., et al.
Schizophrenia Research , cilt.229, ss.27-37, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier

23. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

Pries L. -., Dal Ferro G. A., van Os J., Delespaul P., Kenis G., Lin B. D., et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES , cilt.29, 2020 (SCI-Expanded) identifier identifier identifier

24. Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia A Real-World Multicenter, Retrospective, Mirror-Image Study

Devrimci-Ozguven H., ATMACA M., Baran Z., Cengisiz C., Cinar C., Erol A., et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.39, sa.6, ss.604-610, 2019 (SCI-Expanded) identifier identifier identifier

25. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

Schepers E., Lousberg R., Guloksuz S., Pries L., Delespaul P., Kenis G., et al.
FRONTIERS IN PSYCHIATRY , cilt.10, 2019 (SCI-Expanded) identifier identifier identifier

26. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

Pries L., Lage-Castellanos A., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
SCHIZOPHRENIA BULLETIN , cilt.45, sa.5, ss.960-965, 2019 (SCI-Expanded) identifier identifier identifier

27. A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale

Mucci A., Vignapiano A., Bitter I., Austin S. F., Delouche C., Dollfus S., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.29, sa.8, ss.947-959, 2019 (SCI-Expanded) identifier identifier identifier

28. Lower prepulse inhibition in clinical high-risk groups but not in familial risk groups for psychosis compared with healthy controls

Togay B., Cikrikcili U., Bayraktaroglu Z., Uslu A., Noyan H., Ucok A.
EARLY INTERVENTION IN PSYCHIATRY , 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

29. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

Guloksuz S., Pries L., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
WORLD PSYCHIATRY , cilt.18, sa.2, ss.173-182, 2019 (SCI-Expanded) identifier identifier identifier

30. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia

Ucok A., Yagcioglu E. A., YILDIZ M., Kaymak S. U., SAKA M. C., Tasdelen R., et al.
PSYCHIATRY RESEARCH , cilt.275, ss.149-154, 2019 (SCI-Expanded) identifier identifier identifier

31. Psychometric liability to psychosis and childhood adversities are associated with shorter telomere length: A study on schizophrenia patients, unaffected siblings, and non-clinical controls

Cevik B., MANÇE ÇALIŞIR Ö., Atbasoglu E. C., SAKA M. C., ALPTEKİN K., ÜÇOK V. A., et al.
JOURNAL OF PSYCHIATRIC RESEARCH , cilt.111, ss.169-185, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

32. Responding to experienced and anticipated discrimination (READ): anti -stigma training for medical students towards patients with mental illness - study protocol for an international multisite non-randomised controlled study

Deb T., Lempp H., Bakolis I., Vince T., Waugh W., Henderson C., et al.
BMC MEDICAL EDUCATION , cilt.19, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

33. The impact of a six-month interpersonal group psychotherapy on functionality of patients with schizophrenia in a community mental health center

Sukru F., Ozturk M., Kilic O., Ister Guneytepe S., Ucok A.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.19, sa.6, ss.559-566, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

34. Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

ATBAŞOĞLU E. C., Gumus-Akay G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., et al.
PSYCHOPHARMACOLOGY , cilt.235, sa.4, ss.1029-1039, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

35. Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis

Soyata A. Z., Akisik S., Inhanli D., Noyan H., Ucok A.
PSYCHIATRY RESEARCH , cilt.261, ss.332-337, 2018 (SCI-Expanded) identifier identifier identifier

36. Relationship Between Persistent Negative Symptoms and Findings of Neurocognition and Neuroimaging in Schizophrenia

Ince E., Ucok A.
CLINICAL EEG AND NEUROSCIENCE , sa.1, ss.27-35, 2018 (SCI-Expanded) identifier identifier identifier

37. Electrophysiological and Neuroimaging Research on Negative Symptoms: Future Challenges

Mucci A., Ucok A., Nielsen M. O.
CLINICAL EEG AND NEUROSCIENCE , cilt.49, sa.1, ss.3-5, 2018 (SCI-Expanded) identifier identifier identifier

38. Deficits in Go and NoGo P3 potentials in patients with schizophrenia.

ERTEKIN E., Üçok A., KESKIN-ERGEN Y., DEVRIM-ÜÇOK M.
Psychiatry research , cilt.254, ss.126-132, 2017 (SCI-Expanded) identifier identifier identifier

39. Primary and persistent negative symptoms: Concepts, assessments and neurobiological bases

Mucci A., MERLOTTI E., Ucok A., ALEMAN A., Galderisi S.
SCHIZOPHRENIA RESEARCH , cilt.186, ss.19-28, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

40. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

Howes O. D., McCutcheon R., Agid O., de Bartolomeis A., van Beveren N. J. M., Birnbaum M. L., et al.
AMERICAN JOURNAL OF PSYCHIATRY , cilt.174, sa.3, ss.216-229, 2017 (SCI-Expanded) identifier identifier identifier

41. The Relationship of Negative Symptom Severity with Cognitive Symptoms and Functioning in Subjects at Ultra High Risk for Psychosis

Ucok A., Cikrikcili U., Noyan H., Tabak O., Yokusoglu C., Samanli H. K., et al.
EARLY INTERVENTION IN PSYCHIATRY , cilt.10, ss.88, 2016 (SCI-Expanded) identifier

42. Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study

Ucok A., Cikrikcili U., Ergul C., Tabak O., Salaj A., Karabulut S., et al.
CNS DRUGS , cilt.30, sa.10, ss.997-1006, 2016 (SCI-Expanded) identifier identifier identifier

43. Lack of progressive reduction in P3 amplitude after the first-episode of schizophrenia: A 6-year follow-up study

Devrim-Ucok M., Keskin-Ergen Y., Ucok A.
PSYCHIATRY RESEARCH , cilt.243, ss.303-311, 2016 (SCI-Expanded) identifier identifier identifier

44. Discrimination in the workplace, reported by people with major depressive disorder: a cross-sectional study in 35 countries

Brouwers E. P. M., Mathijssen J., Van Bortel T., Knifton L., Wahlbeck K., Van Audenhove C., et al.
BMJ OPEN , cilt.6, sa.2, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

45. Validation of Turkish version of brief negative symptom scale

Polat Nazli I., Ergul C., Aydemir O., Chandhoke S., Ucok A., Gönül A. S.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE , cilt.20, sa.4, ss.265-271, 2016 (SCI-Expanded) identifier identifier identifier

46. Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Schreiner A., Aadamsoo K., Altamura A. C., Franco M., Gorwood P., Neznanov N. G., et al.
SCHIZOPHRENIA RESEARCH , cilt.169, ss.393-399, 2015 (SCI-Expanded) identifier identifier identifier

47. Clinical variables associated with suicide attempts in schizophrenia before and after the first episode

Togay B., Noyan H., Tasdelen R., Ucok A.
PSYCHIATRY RESEARCH , cilt.229, ss.252-256, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

48. Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia

Ucok A., Cikrikcili U., Karabulut S., Salaj A., Ozturk M., Tabak O., et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , cilt.30, sa.5, ss.290-295, 2015 (SCI-Expanded) identifier identifier identifier

49. Effects of paliperidone extended release on functioning level and symptoms of patients with recent onset schizophrenia: An open-label, single-arm, flexible-dose, 12-months follow-up study

Ucok A., Saka M. C., BILICI M.
NORDIC JOURNAL OF PSYCHIATRY , cilt.69, sa.6, ss.1708-1714, 2015 (SCI-Expanded) identifier identifier identifier

50. Negative symptom subgroups have different effects on the clinical course of schizophrenia after the first episode: A 24-month follow up study

Ergul C., Ucok A.
EUROPEAN PSYCHIATRY , cilt.30, sa.1, 2015 (SCI-Expanded) identifier identifier identifier

51. Obsessive compulsive symptoms are related to lower quality of life in patients with Schizophrenia

Ucok A., Tihan A. K., Karadayi G., Tukel R.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE , cilt.18, sa.4, ss.243-247, 2014 (SCI-Expanded) identifier identifier identifier

52. Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic

ALPTEKİN K., Ucok A., Ayer A., Unal A., Erol A., Ensari H., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.24, sa.3, ss.276-288, 2014 (SCI-Expanded) identifier identifier identifier

53. Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study

Ucok A., Ergul C.
SCHIZOPHRENIA RESEARCH , cilt.158, ss.241-246, 2014 (SCI-Expanded) identifier identifier identifier

54. Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations

van Os J., Rutten B. P., Myin-Germeys I., Delespaul P., Viechtbauer W., van Zelst C., et al.
SCHIZOPHRENIA BULLETIN , cilt.40, sa.4, ss.729-736, 2014 (SCI-Expanded) identifier identifier identifier

55. The role of metformin and topiramate in reducing the side effects due to antipsychotics in patients with schizophrenia

Karabulut S., Ergul C., Ozturk M., Ucok A.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.15, sa.2, ss.174-180, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

56. Factor structure of the Subjective Well-being under Neuroleptic treatment Scale-short form in schizophrenic outpatients: Five factors or only one?

Pazvantoglu O., Simsek O. F., Aydemir O., Sarisoy G., Boke O., Ucok A.
NORDIC JOURNAL OF PSYCHIATRY , cilt.68, sa.4, ss.259-265, 2014 (SCI-Expanded) identifier identifier identifier

57. NEGATIVE SYMPTOM SUBGROUPS HAVE DIFFERENT EFFECTS ON CLINICAL COURSE AFTER FIRST EPISODE OF SCHIZOPHRENIA: A 24 MONTHS FOLLOW-UP STUDY

Ergul C., Ucok A.
SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded) identifier

58. NEGATIVE SYMPTOM SUBGROUPS HAVE DIFFERENT EFFECTS ON CLINICAL COURSE AFTER FIRST EPISODE OF SCHIZOPHRENIA: A 24-MONTH FOLLOW-UP STUDY

Ergul C., Ucok A.
SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded) identifier

59. P3 ABNORMALITIES IN NEUROLEPTIC-NAIVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS AND IN THEIR HEALTHY SIBLINGS

Devrim-Ucok M., Ucok A.
SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded) identifier

60. PERSISTANT NEGATIVE SYMPTOMS AFTER FIRST-EPISODE SCHIZOPHRENIA; RESULTS OF 2 YEARS FOLLOW-UP

Ucok A., Ergul C.
SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded) identifier

61. A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)

Schreiner A., Aadamsoo K., Altamura C., Franco M., Gorwood P., Neznanov N. G., et al.
SCHIZOPHRENIA RESEARCH , cilt.153, 2014 (SCI-Expanded) identifier

62. A RANDOMIZED, ACTIVE-CONTROLLED RATER-BLINDED 2-YEAR STUDY OF PALIPERIDONE PALMITATE VERSUS INVESTIGATORS' CHOICE OF ORAL ANTIPSYCHOTIC MONOTHERAPY IN PATIENTS WITH SCHIZOPHRENIA (PROSIPAL)

Schreiner A., Aadamsoo K., Altamura A. C., Franco M., Goorwood P., Neznanov N. G., et al.
EUROPEAN PSYCHIATRY , cilt.29, 2014 (SCI-Expanded) identifier

63. Cognitive deficits in clinical and familial high risk groups for psychosis are common as in first episode schizophrenia

Ucok A., Direk N., KOYUNCU A., Keskin-Ergen Y., Yuksel C., GULER J., et al.
SCHIZOPHRENIA RESEARCH , cilt.151, ss.265-269, 2013 (SCI-Expanded) identifier identifier identifier

64. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia

Sahin S., Yuksel C., GULER J., Karadayi G., Akturan E., Gode E., et al.
EARLY INTERVENTION IN PSYCHIATRY , cilt.7, sa.4, ss.414-420, 2013 (SCI-Expanded) identifier identifier identifier

65. Anticipated discrimination is related to symptom severity, functionality and quality of life in schizophrenia

Ucok A., Karadayi G., Emiroglu B., sartorius N.
PSYCHIATRY RESEARCH , cilt.209, sa.3, ss.333-339, 2013 (SCI-Expanded) identifier identifier identifier

66. Reliability and Validity of Subjective Well-Being Under Neuroleptics Scale-Short Form-Turkish Version

Pazvantoglu O., Simsek O. F., AYDEMİR Ö., SARISOY G., Korkmaz I. Z., Mor S., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.22, sa.3, ss.235-243, 2012 (SCI-Expanded) identifier identifier

67. Metabolic Effects of Paliperidone Extended Release Versus Oral Olanzapine in Patients With Schizophrenia A Prospective, Randomized, Controlled Trial

Schreiner A., Niehaus D., Shuriquie N. A., Aadamsoo K., Korcsog P., Salinas R., et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.32, sa.4, ss.449-457, 2012 (SCI-Expanded) identifier identifier identifier

68. Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study

Ucok A., Gorwood P., Karadayi G.
EUROPEAN PSYCHIATRY , cilt.27, sa.6, ss.422-425, 2012 (SCI-Expanded) identifier identifier identifier

69. No gender differences in social outcome in patients suffering from schizophrenia

Galderisi s., bucci p., Ucok A., Peuskens J.
EUROPEAN PSYCHIATRY , cilt.27, sa.6, ss.406-408, 2012 (SCI-Expanded) identifier identifier identifier

70. OBSESSIVE COMPULSIVE SYMPTOMS BUT NOT OBSESSIVE-COMPULSIVE DISORDER ARE RELATED TO LOWER QUALITY OF LIFE IN SCHIZOPHRENIA

ÜÇOK V. A., Tihan A., Tukel R.
SCHIZOPHRENIA RESEARCH , cilt.136, 2012 (SCI-Expanded) identifier

71. Self-stigmatization among patients with schizophrenia, their relatives and patients with major depressive disorder

YILDIZ M., Ozten E., Isik S., Ozyildirim I., Karayun D., Cerit C., et al.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , cilt.13, sa.1, ss.1-7, 2012 (SCI-Expanded) identifier identifier

72. Anticipated discrimination among people with schizophrenia

Ucok A., Brohan E., Rose D., Sartorius N., Leese M., Yoon C. K., et al.
ACTA PSYCHIATRICA SCANDINAVICA , cilt.125, sa.1, ss.77-83, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

73. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia

Karadayi G., Emiroglu B., Ucok A.
COMPREHENSIVE PSYCHIATRY , cilt.52, sa.6, ss.701-707, 2011 (SCI-Expanded) Creative Commons License identifier identifier identifier

74. Remission after first-episode schizophrenia: Results of a long-term follow-up

Ucok A., Serbest S., Kandemir P. E.
PSYCHIATRY RESEARCH , sa.1, ss.33-37, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

75. Obsessive compulsive disorder and symptoms may have different effects on schizophrenia

Ucok A., CEYLAN M. E., Tihan A. K., LAPCIN S., GER C., Tukel R.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.35, sa.2, ss.429-433, 2011 (SCI-Expanded) identifier identifier identifier

76. An Unusual Late Presentation of Subacute Sclerosing Panencephalitis With Psychotic Symptoms

Baran Z., Hanagasi H. A., Ucok A.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.22, sa.1, 2010 (SCI-Expanded) identifier identifier identifier

77. COMT Val158Met polymorphism is related with interpersonal problem solving in schizophrenia

Ucok A., Öztürk M. S., Duman Z., Saruhan-Direskeneli G.
European Psychiatry , cilt.25, sa.6, ss.320-322, 2010 (SCI-Expanded) identifier identifier identifier

78. THE EFFECTIVENESS OF A PSYCHOEDUCATIONAL GROUP PROGRAM WITH INPATIENTS BEING TREATED FOR CHRONIC MENTAL ILLNESS

DUMAN Z. Ç., Yildirim N. K., Ucok A., Er F., Kanik T.
SOCIAL BEHAVIOR AND PERSONALITY , cilt.38, sa.5, ss.657-666, 2010 (SSCI) Sürdürülebilir Kalkınma identifier identifier

79. Validation of the Turkish Version of the "Functional Remission of General Schizophrenia" (FROGS) Scale

Emiroglu B., Karadayi G., AYDEMİR Ö., Ucok A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.46, ss.15-24, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

80. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study

ALPTEKİN K., Hafez J., Brook S., AKKAYA C., Tzebelikos E., Ucok A., et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , cilt.24, sa.5, ss.229-238, 2009 (SCI-Expanded) identifier identifier identifier

81. THE VALIDATION OF TURKISH VERSION OF PERSONAL AND SOCIAL PERFORMANCE SCALE (PSP)

Aydemir O., Ucok A., Danaci A. E., Sarioz F., Canpolat T., Karadayi G., et al.
VALUE IN HEALTH , cilt.12, sa.3, 2009 (SCI-Expanded) identifier

82. Analysis of Social Class by LCA in Patients with Schizophrenia: Change in Psychopathology after 12 Month of Treatment

Saylan M., Ucok A., Uguz S., Treuer T., Sir A.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.19, sa.1, ss.29-38, 2009 (SCI-Expanded) identifier

83. P50 gating at acute and post-acute phases of first-episode schizophrenia

Devrim-Uecok M., Keskin-Ergen H. Y., Ucok A.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.32, sa.8, ss.1952-1956, 2008 (SCI-Expanded) identifier identifier identifier

84. Altered Metabolic Integrity of Corpus Callosum Among Individuals at Ultra High Risk of Schizophrenia and First-Episode Patients

Aydin K., Ucok A., GULER J.
BIOLOGICAL PSYCHIATRY , cilt.64, sa.9, ss.750-757, 2008 (SCI-Expanded) identifier identifier identifier

85. Do psychiatrists examine sexual dysfunction in schizophrenia patients?

Ucok A., Incesu C., Aker T., Erkoc S.
JOURNAL OF SEXUAL MEDICINE , cilt.5, sa.8, ss.2000-2001, 2008 (SCI-Expanded) identifier identifier identifier

86. Side effects of atypical antipsychotics: a brief overview

Ucok A., gaebel W.
WORLD PSYCHIATRY , cilt.7, sa.1, ss.58-62, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

87. Effectiveness of a structured diet program in antipsychotic-induced weight gain in patients with schizophrenia

Direk N., Ucok A.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE , cilt.12, sa.3, ss.238-240, 2008 (SCI-Expanded) identifier identifier identifier

88. The effects of childhood trauma in patients with first-episode schizophrenia

Ucok A., Bikmaz S.
ACTA PSYCHIATRICA SCANDINAVICA , cilt.116, sa.5, ss.371-377, 2007 (SCI-Expanded) identifier identifier identifier

89. Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection

Aydin K., Ucok A., Cakir S.
AMERICAN JOURNAL OF NEURORADIOLOGY , cilt.28, sa.10, ss.1968-1974, 2007 (SCI-Expanded) identifier identifier identifier

90. Antistigma Efforts in Turkey The Turkish Program Against Stigmatization and Discrimination Because of Schizophrenia as a Part of the World Psychiatric Association Global Program

Soygur H., ÜÇOK V. A., Akbiyik D. I.
INTERNATIONAL JOURNAL OF MENTAL HEALTH , cilt.36, sa.3, ss.58-65, 2007 (ESCI) identifier identifier

91. Novelty P3 and P3b in first-episode schizophrenia and chronic schizophrenia

DEVRIM-UCOK M., KESKIN-ERGEN H. Y., Ucok A.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY , cilt.30, sa.8, ss.1426-1434, 2006 (SCI-Expanded) identifier identifier identifier

92. Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia

Ucok A., Cakir S., Duman Z. C., Discigal A., Kandemir P., Atli H.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.256, sa.6, ss.388-394, 2006 (SCI-Expanded) identifier identifier identifier

93. P300 responses in recent-onset schizophrenia patients elicited during N-back task

Keskin-Ergen H. Y., Ertekin E., Ucok A., Devrim-Ucok M.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY , cilt.61, sa.3, ss.345, 2006 (SCI-Expanded) identifier

94. Family centered evaluation of treatment outcome in schizophrenia: Marmara family interview for the Assesment of Psychiatric Treatment

Kuscu M. K., Duman Z. C., Akman M., Ucok A., Goktepe E. O.
TURK PSIKIYATRI DERGISI , cilt.17, sa.3, ss.192-203, 2006 (SSCI) identifier identifier identifier

95. Mismatch negativity at acute and post-acute phases of first-episode schizophrenia

Derim-Ucok M., Keskin-Ergen H. Y., Ucok A.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY , cilt.61, sa.3, ss.345, 2006 (SCI-Expanded) identifier

96. Effects of an antistigma program on medical students' attitudes towards people with schizophrenia

Altindag A., Yanik M., Ucok A., Alptekin K., Ozkan M.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.60, sa.3, ss.283-288, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

97. Electroconvulsive therapy in first-episode schizophrenia

Ucok A., Cakar S.
JOURNAL OF ECT , cilt.22, sa.1, ss.38-42, 2006 (SCI-Expanded) identifier identifier identifier

98. One year outcome in first episode schizophrenia - Predictors of relapse

Ucok A., Polat A., Cakir S., Genc A.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.256, sa.1, ss.37-43, 2006 (SCI-Expanded) identifier identifier identifier

99. Frequency of obsessive compulsive symptoms and disorder in patients with schizophrenia : importence for prognosis

Ucok A., Tukel R., Ozgen G., Saylan M., Uzuner G.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE , cilt.32, sa.1, ss.41-44, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

100. The Efficacy of Psychoeducational Group Therapy in Inpatients

ÇETİNKAYA DUMAN Z., Kocaman N., ÜÇOK V. A., Er F., Kanik T., Doganer M.
DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES , cilt.19, sa.2, ss.64-71, 2006 (ESCI) identifier

101. Histories of childhood maltreatment in first-episode schizophrenia

Ucok A., Bykmaz S.
ACTA PSYCHIATRICA SCANDINAVICA , cilt.114, ss.59, 2006 (SCI-Expanded) identifier

102. Disability in schizophrenia: Clinical correlates and prediction over 1-year follow-up

Alptekin K., Erkoc S., Gogus A., Kultur S., Mete L., Ucok A., et al.
PSYCHIATRY RESEARCH , cilt.135, sa.2, ss.103-111, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

103. Human leukocyte antigen alleles in patients with bipolardisorder in Turkey

Ucok A., Akar U., Polat A.
EUROPEAN PSYCHIATRY , cilt.20, sa.1, ss.83, 2005 (SCI-Expanded) identifier identifier identifier

104. Cigarette smoking among patients with schizophrenia and bipolar disorders

Ucok A., Polat A., Bozkurt O., Meteris H.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.58, sa.4, ss.434-437, 2004 (SCI-Expanded) identifier identifier identifier

105. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia

Ucok A., Polat A., Genc A., Cakir S., Turan N.
JOURNAL OF PSYCHIATRIC RESEARCH , cilt.38, sa.2, ss.163-168, 2004 (SCI-Expanded) identifier identifier identifier

106. Bipolar disorder treatment guidelines of Psychiatric Association of Turkey: Main differences as reflections of countrywide applications and their rationale

Vahip S., Yazici O., Akdeniz F., Gonul A., Karadag F., Kocadere M., et al.
JOURNAL OF AFFECTIVE DISORDERS , cilt.78, 2004 (SCI-Expanded) identifier

107. Attitudes of psychiatrists toward patients with schizophrenia

Ucok A., Polat A., Sartorius N., Erkoc S., Atakli C.
PSYCHIATRY AND CLINICAL NEUROSCIENCES , cilt.58, sa.1, ss.89-91, 2004 (SCI-Expanded) identifier identifier identifier

108. Treatment guidelines for bipolar disorders of Psychiatric Association of Turkey

Vahip S., Yazici O., Akdeniz F., Gonul A., Karadag F., Kocadere M., et al.
ACTA PSYCHIATRICA SCANDINAVICA , cilt.110, ss.40, 2004 (SCI-Expanded) identifier

109. Quetiapine treatment in a patients with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania

Matur Z., Ucok A.
ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES , cilt.40, sa.2, ss.150-152, 2003 (SSCI) identifier identifier identifier

110. Unipolar mania: a distinct disorder?

Yazici O., Kora K., Ucok A., Saylan M., Ozdemir O., Kiziltan E., et al.
JOURNAL OF AFFECTIVE DISORDERS , cilt.71, ss.97-103, 2002 (SCI-Expanded) identifier identifier identifier

111. Predictors of relapse following response from a first episode of schizophrenia

Ucok A., Polat A., Saylan M., Turan N.
SCHIZOPHRENIA RESEARCH , cilt.53, sa.3, ss.54, 2002 (SCI-Expanded) identifier

112. A multi-center 1-year follow-up study of patients with schizophrenia in Turkey: Relapse and its predictors

Ucok A., Kultur S., Alptekin K., Erkoc S., Gogus A., Mete L., et al.
SCHIZOPHRENIA RESEARCH , cilt.53, sa.3, ss.251, 2002 (SCI-Expanded) identifier

113. Relation of family history of schizophrenia with clinical variables in patients with schizophrenia

Ucok A., Kultur S., Alptekin K., Erkoc S., Gogus A., Mete L., et al.
SCHIZOPHRENIA RESEARCH , cilt.53, sa.3, ss.81, 2002 (SCI-Expanded) identifier

114. Disability in schizophrenia: A multicenter study of 1-year follow-up of patients with schizophrenia in Turkey

ALPTEKİN K., Erkoc S., GÖĞÜŞ A. K., Kultur S., Mete L., ÜÇOK V. A., et al.
SCHIZOPHRENIA RESEARCH , cilt.53, sa.3, ss.261, 2002 (SCI-Expanded) identifier

115. Co-morbid substance abuse and smoking in Turkish patients with schizophrenia

ALPTEKİN K., Erkoc S., GÖĞÜŞ A. K., Kultur S., Mete L., ÜÇOK V. A., et al.
SCHIZOPHRENIA RESEARCH , cilt.53, sa.3, ss.224, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

116. Predictors of lithium prophylaxis in bipolar patients

Yazici O., Kora K., Ucok A., Tunali D., Turan N.
JOURNAL OF AFFECTIVE DISORDERS , cilt.55, ss.133-142, 1999 (SCI-Expanded) identifier identifier identifier

117. Comorbidity of personality disorders with bipolar mood disorders

Ucok A., KARAVELI D., KUNDAKCI T., YAZICI O.
COMPREHENSIVE PSYCHIATRY , cilt.39, sa.2, ss.72-74, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

118. Seclusion in closed psychiatric wards in Turkey

Ucok V. A., KORA K., BOSTANCI F., ER F.
EUROPEAN JOURNAL OF PSYCHIATRY , cilt.10, sa.3, ss.149-154, 1996 (SSCI) Sürdürülebilir Kalkınma identifier identifier

119. Maintenance ECT in a patient with catatonic schizophrenia and tardive dyskinesia

Ucok A., Ucok G.
CONVULSIVE THERAPY , cilt.12, sa.2, ss.108-112, 1996 (SCI-Expanded) identifier identifier identifier

120. NORADRENERGIC AND SEROTONINERGIC DEPRESSION

YAZICI O., ARICIOGLU F., GURVIT G., UCOK A., TASTABAN Y., CANBERK O., et al.
JOURNAL OF AFFECTIVE DISORDERS , cilt.27, sa.2, ss.123-129, 1993 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 25

1. Pregnancy and postpartum period associated severe mental disorders in a hospital-based cohort

Büyüktopcu E., Gürşahbaz O. C., Ergün S., Keskin M., Köroğlu S. B., Ozan E., et al.
35th ECNP Congress, Vienna, Avusturya, 15 - 18 Ekim 2022, cilt.1,2, ss.357-358, (Özet Bildiri)

2. Bipolar bozukluk ile komplike olan Graves hastalığı

Doğan E. E., Mutlu Ü., Hacişahinoğulları H., Gürşahbaz O. C., Üçok V. A., Soyluk Selçukbiricik Ö., et al.
Endokurs 5, Antalya, Türkiye, 10 - 14 Kasım 2021, ss.148, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

3. Negatif Belirtiler Özdeğerlendirme Ölçeğinin Türkçe Geçerlik ve Güvenilirlik Çalışması

Polat I., İnce Guliyev E., Elmas S., Abdulhamid S., Aydemir Ö., Üçok V. A.
55. Ulusal Psikiyatri Kongresi, İstanbul, Türkiye, 23 - 27 Ekim 2019, cilt.30, ss.44, (Özet Bildiri)

4. RELATIONSHIP BETWEEN FORMAL THOUGHT DISORDER, AND FUNCTIONING IN INDIVIDUALS WITH ULTRA HIGH RISK FOR PSYCHOSIS

Ucok A., Senay O., Karakas B.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florida, Amerika Birleşik Devletleri, 10 - 14 Nisan 2019, cilt.45, (Özet Bildiri) identifier

5. Neurocognition for the classification of first episode schizophrenia, unaffected family members and healthy controls: A machine learning study

Ince E., Kalmady S. V., Greiner R., Dursun S., Ucok A.
31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, İspanya, 6 - 09 Ekim 2018, (Özet Bildiri) identifier

6. ŞİZOFRENİ HASTALARI VE KARDEŞLERİNDE KİNÜRENİN YOLAĞI METABOLİTLERİ, VİTAMİN D VE İNFLAMASYON BELİRTEÇLERİNİN KOGNİSYON VE KLİNİK BELİRTİLERLE İLİŞKİSİ

Noyan H., TÜZÜN E., Erdağ E., HAKAN M. T., KÜÇÜKHÜSEYİN Ö., YAYLIM İ., et al.
II. Türkiye in vitro Diyagnostik(IVD)Sempozyumu, İzmir, Türkiye, 10 - 22 Mayıs 2017, ss.1, (Tam Metin Bildiri)

7. LOWER PREPULSE INHIBITION IN CLINICAL HIGH-RISK GROUP BUT NOT IN FAMILIAL RISK GROUP FOR PSYCHOSIS COMPARED TO HEALTHY CONTROLS

Ucok A., Togay B., Cikrikcili U., Bayraktaroglu Z.
16th International Congress on Schizophrenia Research (ICOSR), California, Amerika Birleşik Devletleri, 24 - 28 Mart 2017, cilt.43, (Özet Bildiri) identifier

8. Psikoz için yüksek risk grubundaki bireylerde dinlenim durumu fonksiyonel manyetik rezonans görüntüleme bulgularının sağlıklı kontroller ile karşılaştırılması

BÜLBÜL Ö., KURT E., Ulaşoğlu Yıldız Ç., Kıçik A., DEMİRALP T., Noyan H., et al.
52. Ulusal Psikiyatri Kongresi, Antalya, Türkiye, 16 - 20 Kasım 2016, ss.11-12, (Tam Metin Bildiri)

9. Kısa Negatif Belirti Ölçeğinin Türkçe Geçerlilik ve Güvenilirlik Çalışması

Polat I., Ergül C., Aydemir Ö., Üçok V. A., Gönül A. S.
51. Ulusal Psikiyatri Kongresi, Antalya, Türkiye, 25 - 29 Kasım 2015, ss.77, (Özet Bildiri)

10. Şizofrenili Hastalarda Anhedoninin Alt Bileşenleri ile İlgili Değişkenler

Ergül C., Polat I., Aydemir Ö., Gönül A. S., Üçok V. A.
51. Ulusal Psikiyatri Kongresi, Antalya, Türkiye, 25 - 29 Kasım 2015, ss.129, (Özet Bildiri)

11. Şizofrenili Hastalarda Negatif Belirtiler ile İlgili Değişkenler

Ergül C., Polat Nazli I., Aydemir Ö., Gönül A. S., Üçok V. A.
51. Ulusal Psikiyatri Kongresi, Antalya, Türkiye, 25 - 29 Kasım 2015, ss.129, (Özet Bildiri)

12. HISTORY OF CHILDHOOD PHYSICAL TRAUMA HAS A NEGATIVE IMPACT ON COGNITIVE FUNCTIONING IN INDIVIDUALS AT ULTRA HIGH RISK FOR PSYCHOSIS

Ucok A.
15th International Congress on Schizophrenia Research (ICOSR), Colorado, Amerika Birleşik Devletleri, 28 Mart - 01 Nisan 2015, cilt.41, (Özet Bildiri) identifier

13. evalualtion ofcognition in the first degree relatives of patients with schizophreia: Association between negative schizotypal personality traits and cognitive dysfunctions

Noyan H., ÜÇOK V. A.
1st Joint Turkish-German Symposium on human neuroscience, Berlin, Almanya, 5 - 07 Haziran 2014, cilt.1, sa.1, ss.30-31, (Tam Metin Bildiri) Creative Commons License

14. P300 AMPLITUDE REDUCTION IN SUBJECTS AT ULTRA HIGH-RISK FOR PSYCHOSIS

Keskin-Ergen H. Y., Ucok A., Gode E., Devrim-Ucok M.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, İtalya, 10 - 14 Nisan 2010, cilt.117, ss.361-362, (Özet Bildiri) identifier

15. CHILDHOOD TRAUMA MAY BE RELATED TO TRANSITION TO PSYCHOSIS IN ULTRA HIGH RISK INDIVIDUALS

Sahin S., ÜÇOK V. A., Code E., Yuksel C.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, İtalya, 10 - 14 Nisan 2010, cilt.117, ss.204, (Özet Bildiri) identifier

16. GO AND NOGO P300 ARE NOT IMPAIRED IN SUBJECTS AT ULTRA HIGH-RISK FOR PSYCHOSIS

Devrim-Ucok M., Keskin-Ergen H. Y., Yuksel C., Sahin S., Ucok A.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, İtalya, 10 - 14 Nisan 2010, cilt.117, ss.245, (Özet Bildiri) identifier

17. A prospective randomized controlled trial of paliperidone ER versus oral olanzapine in patients with schizophrenia

Schreiner A., Korcsog P., Niehaus D. J., Aadamsoo K., Ucok A., Franco M., et al.
27th Collegium Internationale Neuro-Psychopharmacologicum Congress, Hong Kong, PEOPLES R CHINA, 6 - 10 Haziran 2010, cilt.13, ss.239, (Özet Bildiri) identifier

18. P3B AMPLITUDE REDUCTION IS NOT PROGRESSIVE OVER THE COURSE OF SCHIZOPHRENIA AFTER THE ONSET OF ILLNESS

Ucok A., Ergen Y. K., Ucok M. D.
12th International Congress on Schizophrenia Research, California, Amerika Birleşik Devletleri, 28 Mart - 01 Nisan 2009, cilt.35, ss.44, (Özet Bildiri) identifier

19. Single-voxel quantitative proton MR spectroscopy in corpus callosum of patients with schizophrenia: Suggests callosal disconnection

Ucok A., Aydin K., Cakir S., Ciftci K.
10th International Congress on Schizophrenia Research, Savannakhet, Laos, 2 - 06 Nisan 2005, cilt.33, ss.358, (Özet Bildiri) identifier

20. Association of cognitive functions and interpersonal problem solving capacity with serotonin (102T/C) receptor polymorphism in schizophrenia

Ucok A., Alpsan H., Cakir S., Ozdemir F., Direskeneli G.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, İsviçre, 4 - 10 Şubat 2006, cilt.81, ss.197, (Özet Bildiri) identifier

21. Nogo P3 reduction reflects impairment in response inhibition processes in recent-onset schizophrenia

Ertekin E., Keskin-Ergen H., Ucok M., Ucok A.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, İsviçre, 4 - 10 Şubat 2006, cilt.81, ss.110-111, (Özet Bildiri) identifier

22. Evaluation of sexual functions of schizophrenic patients under antipsychotics: Multicentered, uninterventional, cross-sectional, epidemiologic study

Aker T., ÜÇOK V. A., Incesu C., Erkoc S.
18th ECNP Congress 2005, Amsterdam, Hollanda, 22 - 26 Ekim 2005, cilt.15, (Özet Bildiri) identifier

23. P3B and novelty P3A in first-episode and chronic schizophrenia

Ucok M., Ucok A., Keskin Y., Cakir S., Discigil A., Polat A.
12th Biennial Winter Workshop on Schizophrenia, DAVOS, İsviçre, 7 - 13 Şubat 2004, cilt.67, ss.134, (Özet Bildiri) identifier

24. Cognitive predictors of skill acquisition on interpersonal problem solving in patients with schizophrenia

Ucok A., Cetinkaya Z., Cakir S., Discigil A., Kandemir P., Atli H.
12th Biennial Winter Workshop on Schizophrenia, DAVOS, İsviçre, 7 - 13 Şubat 2004, cilt.67, ss.261, (Özet Bildiri) identifier

25. The distribution of suicidal behavior and risk factors in patients diagnosed with schizophrenia in a one-year multicenter follow-up study

GÖĞÜŞ A. K., ALPTEKİN K., Erkoc S., Kultur S., Mete L., ÜÇOK V. A., et al.
9th International Congress on Schizophrenia Research, COLORADO SPINGS, COLORADO, 29 Mart - 02 Nisan 2003, cilt.60, ss.16, (Özet Bildiri) identifier
Kitaplar 4

1. İlk episod şizofreni ; yaklaşım ve tedavi ilkeleri

ÜÇOK V. A.
Temel ve Klinik Psikiyatri, K Oğuz Karamustafalıoğlu, Editör, Güneş Tıp Kitapevi Yayınları, Ankara, ss.229-234, 2018

2. Şizofreni

ÜÇOK V. A., ALNAK A.
Maudsley Psikiyatride Reçeteleme Rehberi, Üçok A, Editör, Ema Tıp Kitabevi, İstanbul, ss.44-201, 2017

3. Mikroplar ve psikiyatrik bozukluklar

ÜÇOK V. A.
Enfeksiyon patogenezi ve bağışıklık, Badur S., Abacıoğlu H., Öngen B., Editör, Akademi Yayınevi, İstanbul, ss.1341-1345, 2015

4. Psikanalitik Kurama Giriş

AKVARDAR Y., TÜKEL M. R., ÜÇOK V. A., YÜCEL B.
Bağlam, 2000
Metrikler

Yayın

149

Yayın (WoS)

136

Yayın (Scopus)

119

Atıf (WoS)

3992

H-İndeks (WoS)

34

Atıf (Scopus)

1969

H-İndeks (Scopus)

25

Proje

20

Açık Erişim

10
BM Sürdürülebilir Kalkınma Amaçları